EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC 4.0

Persistence to statin treatment: A cohort study in Lithuania

Karina Kirilova, Indrė Trečiokienė iD, Nomeda Bratčikovienė, Miriam Qvarnström, Björn Wettermark iD

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14015 ↗

At a glance

Kohortenstudie in Basic & Clinical Pharmacology & Toxicology, 2024. Written by Karina Kirilova and 4 co-authors. Institution: Pharmacyand Pharmacology Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Major MEDLINE topics: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Drug Monitoring. Cited 6 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiovascular diseases are the main causes of death, and statins can reduce the risk of major vascular events. Lithuania is among the European countries with the highest cardiovascular mortality despite a rapidly increasing use of statins. Previous reviews have shown the problem of poor patient adherence, but there are limited studies from Eastern European countries. The aim of this study was to evaluate treatment persistence in new users of statins in Lithuania and to investigate factors associated with persistence. Dispensed prescriptions from patients aged >18 years old initiated on statins in 2018–2019 were included, and data were obtained from a national health insurance fund. Persistence was assessed by the proportion of patients who still had statins dispensed 1 year after the first dispensing. Factors associated with persistence were assessed using logistic regression. A total of 104 726 patients (41.3% men) were initiated on statin treatment. Only 41% of them continued statin use 1 year after initiation. Factors associated with higher persistence rate were older age, higher dose of statin, use of other medicines and use of statins as secondary prevention. Low persistence to statin therapy needs to be recognized by healthcare workers, pharmacists and policy makers to address this problem.

Subjects

MeSH terms (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular DiseasesDrug MonitoringHumansLithuaniaMaleFemaleMiddle AgedAgedCohort StudiesAdultSecondary PreventionAge Factors

Author keywords

adherencedrug utilizationpersistencepharmacoepidemiologystatins

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Authors and institutions

  • Pharmacyand Pharmacology Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands.
  • Department of Mathematical Statistics, Faculty of Fundamental Sciences, Vilnius Tech, Vilnius, Lithuania.
  • Department of Human and Medical Genetics, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.

ORCID profiles: Indrė Trečiokienė, Björn Wettermark

Cite

APA

Kirilova, K., Trečiokienė, I., Bratčikovienė, N., Qvarnström, M., & Wettermark, B. (2024). Persistence to statin treatment: A cohort study in Lithuania. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14015

Vancouver

Kirilova K, Trečiokienė I, Bratčikovienė N, Qvarnström M, Wettermark B. Persistence to statin treatment: A cohort study in Lithuania. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14015

BibTeX
@article{Kirilova2024,
  author = {Kirilova, Karina and Trečiokienė, Indrė and Bratčikovienė, Nomeda and Qvarnström, Miriam and Wettermark, Björn},
  title = {Persistence to statin treatment: A cohort study in Lithuania},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14015}
}
Start for free →